批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/01/12 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/08/07 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/08/07 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/08/07 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/08/07 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/08/07 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/08/07 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/08/07 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/05/01 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/07/27 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/05/19 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/05/19 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/05/19 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/05/19 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/06/05 |
ORIG-1(原始申请) |
Approval |
Not Applicable |
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:MESALAMINE 剂型/给药途径:TABLET, DELAYED RELEASE;ORAL 规格:1.2GM 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022000 |
001 |
NDA |
LIALDA |
MESALAMINE |
TABLET, DELAYED RELEASE;ORAL |
1.2GM |
Prescription |
Yes |
Yes |
AB |
2007/01/16
|
TAKEDA PHARMS USA |
091640 |
001 |
ANDA |
MESALAMINE |
MESALAMINE |
TABLET, DELAYED RELEASE;ORAL |
1.2GM |
Prescription |
No |
No |
AB |
2017/06/05
|
ZYDUS PHARMS |
203817 |
001 |
ANDA |
MESALAMINE |
MESALAMINE |
TABLET, DELAYED RELEASE;ORAL |
1.2GM |
Prescription |
No |
No |
AB |
2018/03/23
|
ACTAVIS LABS FL |
211858 |
001 |
ANDA |
MESALAMINE |
MESALAMINE |
TABLET, DELAYED RELEASE;ORAL |
1.2GM |
Prescription |
No |
No |
AB |
2019/01/25
|
SUN PHARM |
217337 |
001 |
ANDA |
MESALAMINE |
MESALAMINE |
TABLET, DELAYED RELEASE;ORAL |
1.2GM |
Prescription |
No |
No |
AB |
2023/05/12
|
SINOTHERAPEUTICS INC |
216334 |
001 |
ANDA |
MESALAMINE |
MESALAMINE |
TABLET, DELAYED RELEASE;ORAL |
1.2GM |
Prescription |
No |
No |
AB |
2024/02/05
|
ANNORA PHARMA |